UB Paderborn / Katalog / Suche / in CDI

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2021-11, Vol.24 (6), p.1330-1340

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 487

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(437)
Mit Volltextzugriff
(462)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(296)
Life Sciences & Biomedicine
(217)
Humans
(149)
Oncology
(105)
Female
(75)
Male
(71)
Middle Aged
(60)
Physical Sciences
(59)
Aged
(58)
Adult
(52)
Chemotherapy
(49)
Technology
(48)
Tumors
(44)
Cancer
(34)
Animals
(32)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(31)
Chemistry
(31)
Treatment Outcome
(31)
Biological And Medical Sciences
(30)
Patients
(30)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(5)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Angiogenesis in metastatic colorectal cancer and the benefits of targeted therapy

Recent advances in cancer immunotherapy

The Role of Angiogenesis in Hepatocellular Carcinoma

The integration of immune checkpoint inhibitors with VEGF targeted agents in advanced gastric and gastroesophageal adenocarcinoma: a review on the rationale and results of early phase trials

The University of Kansas Cancer Center (KUCC), an NCI designated comprehensive cancer center

A Phase I Study of an Agonist CD40 Monoclonal Antibody (CP-870,893) in Combination with Gemcitabine in Patients with Advanced Pancreatic Ductal Adenocarcinoma

Gastric cancer: current and evolving treatment landscape

CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans

Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised controlled trials

Editorial: Recent advances of drug resistance research in colorectal cancer therapy

Similar response rates and survival with PARP inhibitors for patients with solid tumors harboring somatic versus Germline BRCA mutations: a Meta-analysis and systematic review

Targeted therapy in biliary tract cancers-current limitations and potentials in the future

A Phase II and Biomarker Study of Ramucirumab, a Human Monoclonal Antibody Targeting the VEGF Receptor-2, as First-Line Monotherapy in Patients with Advanced Hepatocellular Cancer

Circulating Tumor DNA as a Minimal Residual Disease Assessment and Recurrence Risk in Patients Undergoing Curative-Intent Resection with or without Adjuvant Chemotherapy in Colorectal Cancer: A Systematic Review and Meta-Analysis

Phase II Study of Sorafenib in Combination With Docetaxel and Cisplatin in the Treatment of Metastatic or Advanced Gastric and Gastroesophageal Junction Adenocarcinoma: ECOG 5203

Preoperative treatment of locally advanced rectal cancer: less is more

Prospective study of germline genetic testing in incident cases of pancreatic adenocarcinoma

Weijing Sun, MD, FACP, Reviews Trends in Gastrointestinal Cancer

Weijing Sun, MD, FACP, Reviews Trends in Gastrointestinal Cancer: "... we don't focus on survivorship enough. It's important to understand the other factors involved in surviving besides just a treatment"

Relating Gut Microbiome and Its Modulating Factors to Immunotherapy in Solid Tumors: A Systematic Review

Chemoembolization of Intrahepatic Cholangiocarcinoma With Cisplatinum, Doxorubicin, Mitomycin C, Ethiodol, and Polyvinyl Alcohol: A 2-Center Study

Metastatic Tumor-in-a-Dish, a Novel Multicellular Organoid to Study Lung Colonization and Predict Therapeutic Response

Clinical and biomarker results from a phase II trial of combined cabozantinib and durvalumab in patients with chemotherapy-refractory colorectal cancer (CRC): CAMILLA CRC cohort

A novel outpatient regimen in management of fluoropyrimidine-induced cardiotoxicity

Health-related quality of life in advanced gastric/gastroesophageal junction cancer with second-line pembrolizumab in KEYNOTE-061

Suchergebnisse filtern